Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment

Rationale: Pulmonary exacerbations (PExs) are associated with significant morbidity in people with cystic fibrosis (CF). Severe PExs are treated with intravenous antibiotics, including tobramycin. CF care guidelines recommend continuing chronic maintenance medications during PEx treatment. Azithromy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Am Thorac Soc
Main Authors: Cogen, Jonathan D., Faino, Anna V., Onchiri, Frankline, Gibson, Ronald L., Hoffman, Lucas R., Kronman, Matthew P., Rosenfeld, Margaret, Nichols, David P.
Formato: Artigo
Idioma:Inglês
Publicado: American Thoracic Society 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869777/
https://ncbi.nlm.nih.gov/pubmed/32810412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.202002-176OC
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares